Fig. 5From: Docking and ADMET studies for investigating the anticancer potency of Moscatilin on APC10/DOC1 and PKM2 against five clinical drugsThe bioavailability radar of the ligands, evaluated through SwissADME web tool. The ligands used were a Moscatilin, b Resveratrol, c Mitomycin-C, d Colchicine, e Paclitaxel, and f Shikonin. The colored zone specifies the relevant physicochemical space for oval bioavailabilityBack to article page